Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cryolife Inc (CRY)  
$20.27 0.65 (3.11%) as of 4:30 Thu 4/25


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 37,860,000
Market Cap: 767.42(M)
Last Volume: 190,588 Avg Vol: 219,704
52 Week Range: $12.33 - $21.64
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Specialized Health Services

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P SMALLCAP 600

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Artivion is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. Co. has the following product families: aortic stents and stent grafts, surgical sealants, On-X® mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stents and stent grafts include JOTEC® stent grafts and surgical products, the Ascyrus Medical Dissection Stent hybrid prosthesis, and the NEXUS® endovascular stent graft system. Surgical sealants include BioGlue® Surgical Adhesive products.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 259,909 311,198 333,781 515,621
Total Sell Value $5,066,485 $6,002,697 $6,351,343 $8,882,677
Total People Sold 9 9 10 11
Total Sell Transactions 61 65 67 94
End Date 2024-01-25 2023-10-24 2023-04-25 2022-04-25

   
Records found: 918
  Page 1 of 37  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Stanton Marshall S. SVP, Clinical & MD Affair   •       –      –    2024-03-20 4 S $20.39 $44,511 D/D (2,183) 83,296 2%     
   Green Andrew M VP Regulatory   •       –      –    2024-03-15 4 AS $20.00 $29,240 D/D (1,462) 41,121 1%     
   Green Andrew M VP Regulatory   •       –      –    2024-03-14 4 AS $20.00 $79,880 D/D (3,994) 42,583 -0%     
   Getz Matthew A VP, Human Resources   •       –      –    2024-03-12 4 S $19.94 $99,720 D/D (5,000) 43,536 -1%     
   Horton Amy VP, Chief Accounting Officer   •       –      –    2024-03-05 4/A S $18.72 $21,568 D/D (1,152) 139,989     -
   Maney Rochelle L. VP, Quality   •       –      –    2024-03-05 4/A S $18.72 $21,662 D/D (1,157) 46,569     -
   Holloway Jean F SVP, General Counsel   •       –      –    2024-03-05 4/A S $18.72 $44,559 D/D (2,380) 169,711     -
   Green Andrew M VP Regulatory   •       –      –    2024-03-05 4/A S $18.72 $21,718 D/D (1,160) 46,577     -
   Davis John E Chief Commercial Officer   •       –      –    2024-03-05 4/A S $18.72 $37,856 D/D (2,022) 165,690     -
   Getz Matthew A VP, Human Resources   •       –      –    2024-03-05 4/A S $18.72 $21,661 D/D (1,157) 48,536     -
   Mackin James P President & CEO   •       –      –    2024-03-05 4/A S $18.72 $262,037 D/D (13,996) 706,038     -
   Maney Rochelle L. VP, Quality   •       –      –    2024-03-05 4 S $18.72 $21,662 D/D (1,157) 46,536 -9%     
   Davis John E Chief Commercial Officer   •       –      –    2024-03-05 4 S $18.72 $37,856 D/D (2,022) 165,637 -9%     
   Holloway Jean F SVP, General Counsel   •       –      –    2024-03-05 4 S $18.72 $44,559 D/D (2,380) 169,669 -9%     
   Green Andrew M VP Regulatory   •       –      –    2024-03-05 4 S $18.72 $21,718 D/D (1,160) 46,541 -9%     
   Stanton Marshall S. SVP, Clinical & MD Affair   •       –      –    2024-03-05 4 S $18.72 $28,195 D/D (1,506) 85,438 -9%     
   Getz Matthew A VP, Human Resources   •       –      –    2024-03-05 4 S $18.72 $21,661 D/D (1,157) 48,503 -9%     
   Horton Amy VP, Chief Accounting Officer   •       –      –    2024-03-05 4 S $18.72 $21,568 D/D (1,152) 139,957 -9%     
   Mackin James P President & CEO   •       –      –    2024-03-05 4 S $18.72 $262,037 D/D (13,996) 705,562 -9%     
   Horton Amy VP, Chief Accounting Officer   •       –      –    2024-03-01 4/A A $0.00 $0 D/D 3,578 141,141     -
   Maney Rochelle L. VP, Quality   •       –      –    2024-03-01 4/A A $0.00 $0 D/D 3,578 47,726     -
   Holloway Jean F SVP, General Counsel   •       –      –    2024-03-01 4/A A $0.00 $0 D/D 5,724 172,091     -
   Green Andrew M VP Regulatory   •       –      –    2024-03-01 4/A A $0.00 $0 D/D 3,578 47,737     -
   Davis John E Chief Commercial Officer   •       –      –    2024-03-01 4/A A $0.00 $0 D/D 5,724 167,712     -
   Stanton Marshall S. SVP, Clinical & MD Affair   •       –      –    2024-03-01 4/A S $18.72 $28,195 D/D (1,506) 85,479     -
  918 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 37
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us